Comments

Solid Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Solid Biosciences (SLDB) operate in?

Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SLDBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.74

At close: Apr 9 EDT

$2.80

0.062.13%

Pre-Market: 7:54 PM EDT

Solid Biosciences (SLDB) Forecast

News Earnings Solid Biosciences (SLDB) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Solid Biosciences Stock Price, Quotes and Forecasts | NASDAQ:SLDB | Benzinga

Explore Solid Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SLDB.

Open	-
Close	-
Volume / Avg.	17.00 / 2.47M
Day Range	- - -
52 Wk Range	2.48 - 11.99
Market Cap	$216.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	12.04%
Days to Cover	6.4

Recent News

Can Solid Biosciences Challenge Sarepta in the DMD Market?

When it comes to treating Duchenne muscular dystrophy (DMD), big news recently surfaced. DMD is a muscle disease. It usually first shows up in boys aged two to five years. Genetic alterations cause it, and the condition

MarketBeat

Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?

Shares of biotech company Solid Biosciences (NASDAQ:SLDB) skyrocketed on Feb. 18 after the firm released key clinical data. Solid shares ended the day up nearly 32%. So, what information came out resulting in this

MarketBeat

Solid Biosciences Stock Surges On Upbeat Duchenne Muscular Dystrophy Gene Therapy Data

Solid Biosciences' SGT-003 gene therapy showed strong dystrophin expression, muscle health improvements, and no serious safety concerns in early trial data.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	17.00 / 2.47M
Day Range	- - -
52 Wk Range	2.48 - 11.99
Market Cap	$216.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	12.04%
Days to Cover	6.4

About Solid Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and...

Got Questions? Ask

What is SLDB's current market cap?

What is SLDB's current price trend?

What is SLDB's free cash flow?

What is SLDB's gross margin?

What’s the latest news on SLDB?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Solid Biosciences (SLDB) stock?

You can purchase shares of Solid Biosciences (NASDAQ:SLDB) through any online brokerage.

View our list of the best stock brokerages

Who are Solid Biosciences (SLDB) competitors?

Other companies in Solid Biosciences’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN), Anika Therapeutics (NASDAQ:ANIK) and Monte Rosa Therapeutics (NASDAQ:GLUE).

What is the forecast, or price target, for Solid Biosciences (SLDB) stock?

Solid Biosciences has a consensus price target of $15.75.

What is the current price for Solid Biosciences (SLDB)?

The stock price for Solid Biosciences (NASDAQ: SLDB) is $2.7983 last updated April 9, 2025 at 7:54 PM EDT.

Does Solid Biosciences (SLDB) pay a dividend?

There are no upcoming dividends for Solid Biosciences.

When is Solid Biosciences (NASDAQ:SLDB) reporting earnings?

Solid Biosciences’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Is Solid Biosciences (SLDB) going to split?

There is no upcoming split for Solid Biosciences.

What sector and industry does Solid Biosciences (SLDB) operate in?

Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.